Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival analysis of KEYNOTE-006.
Authors
Blank, CLorigan, Paul C
Schachter, J
Robert, C
Ribas, A
Long, G
Arance, A
Mortier, L
Daud, A
Carlino, M
McNeil, C
Lotem, M
Larkin, J
Neyns, B
Petrella, T
Hamid, O
Zhou, H
Ebbinghaus, S
Ibrahim, N
Grob, J
Affiliation
Netherlands Cancer Institute, Amsterdam, NetherlandsIssue Date
2016